Plutux
$5.37
-1.65%
N/A-$0.09
Healthcare
Biotechnology
NASDAQ
Active Trading

Savara Inc. is a biopharmaceutical firm in the clinical development phase, specializing in therapies for uncommon respiratory conditions. Their primary investigational drug, ...

Plutux is not an investment adviser. Market data and AI-generated analysis are for information and education only, not investment advice. Disclaimer

© Plutux Technology Limited 2026
Savara Inc. (SVRA) earnings calendar and key dates